In addition, we demonstrated that blocking the TGF-β cascade in tumor cells inhibits the expression of TGF-β target genes, such as IL-11, CXCR4, and osteopontin, known to enhance bone metastasis formation from breast cancer cells or melanoma [92,93,94,95]. Here, TGFB1 is linked to breast carcinoma.